Q3 2018

Filed Nov 13, 2018 · 10-Q · 44 days after period end · 0001654954-18-012535

Q3 2018 · 10-Q

Revenue

$140.76K

+417.1% vs Q3 2017

Net Income

-$206.98K

N/M vs Q3 2017

EPS Diluted

$0.00

— vs Q3 2017

Operating Income-$147,948N/M

Operating Cash Flow

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$140.76K	$27.22K	$18.67K	$0.00
Net Income	-$206.98K	-$279.79K	-$1.12M	-$348.52K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR